CircHACE1 functions as a competitive endogenous RNA to curb differentiated thyroid cancer progression by upregulating Tfcp2L1 through adsorbing miR-346-Reference-Cited by-同舟云学术

CircHACE1 functions as a competitive endogenous RNA to curb differentiated thyroid cancer progression by upregulating Tfcp2L1 through adsorbing miR-346

Published:2021 Issue:8 Volume:68 Page:1011-1025
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Li Xiangyi¹,Yang Song²,Zhao Chengyuan¹,Yang Jie¹,Li Chen³,Shen Wenhao²,Hu Haitao⁴,Zhang Wei⁵,Yang Shufang¹

Affiliation:

1. Department of Endocrinology, Taizhou People’s Hospital, Taizhou City, Jiangsu Province, China

2. Department of Oncology, Taizhou People’s Hospital, Taizhou City, Jiangsu Province, China

3. Department of Stomatology, Taizhou People’s Hospital, Taizhou City, Jiangsu Province, China

4. Clinical Laboratory, Taizhou People’s Hospital, Taizhou City, Jiangsu Province, China

5. Department of Infectious Diseases, Taizhou People’s Hospital, Taizhou City, Jiangsu Province, China

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/68/8/68_EJ20-0806/_pdf

Reference33 articles.

1. 1 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, et al. (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68: 394–424.

2. 2 Gambardella C, Patrone R, Di Capua F, Offi C, Mauriello C, et al. (2019) The role of prophylactic central compartment lymph node dissection in elderly patients with differentiated thyroid cancer: a multicentric study. BMC Surg 18: 110.

3. 3 Cabanillas ME, McFadden DG, Durante C (2016) Thyroid cancer. Lancet (London, England) 388: 2783–2795.

4. 4 Yamazaki H, Iwasaki H, Takasaki H, Suganuma N, Sakai R, et al. (2019) Efficacy and tolerability of initial low-dose lenvatinib to treat differentiated thyroid cancer. Medicine 98: e14774.

5. 5 Xu N, Chen J, He G, Gao L, Zhang D (2020) Prognostic values of m6A RNA methylation regulators in differentiated thyroid carcinoma. J Cancer 11: 5187–5197.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circular RNAs in Cell Cycle Regulation of Cancers;International Journal of Molecular Sciences;2024-05-31

2. TFCP2L1, a potential differentiation regulator, predicts favorable prognosis and dampens thyroid cancer progression;Journal of Endocrinological Investigation;2024-05-16

3. Emerging roles of circular RNAs in regulating the hallmarks of thyroid cancer;Cancer Gene Therapy;2024-02-05

4. Development of a joint diagnostic model of thyroid papillary carcinoma with artificial neural network and random forest;Frontiers in Genetics;2022-10-07

5. The predictive value of circular RNAs in the diagnosis, prognosis and clinicopathological features of thyroid cancer: A systematic review and meta-analysis;Pathology - Research and Practice;2022-08